Elite members get real-time data, technical charting, alerts, and no ads - starting at $24.96/mo.
Try Elite for Free
Login Sign up free
Home Stock ScreenerScreener ETF ScreenerETF Maps Charts News Groups Insider Futures Forex Crypto Watchlist Portfolio Calendar
Pricing

BOLD

Boundless Bio Inc

Last Close
2.47
Oct 30 • 3:59 PM ET Dollar change-0.01 Percentage change(-0.40%)
Aftermarket Close
2.47
Aftermarket • 4:15 PM ET Dollar change0.00 Percentage change(0.00%)
Overview Compare Short Interest Financials Options Filings Dilution
Healthcare Biotechnology USA Micro NASD
Peers: BEAM KRRO WVE PRME NTLA ARVN ACRV OLMA BDTX CELC
 | Held by: VTI VXF IWC
Scroll to Statements
Index
-
Market Cap
56.19M
Enterprise Value
-16.44M
Income
-64.01M
Sales
0.00M
Book/sh
2.94
Cash/sh
3.19
Dividend Est.
-
Dividend TTM
-
Dividend Ex-Date
-
Dividend Gr. 3/5Y
- -
Payout
-
Employees
28
IPO
Mar 28, 2024
P/E
-
Forward P/E
-
PEG
-
P/S
-
P/B
0.84
P/C
0.77
P/FCF
-
EV/EBITDA
-
EV/Sales
-
Quick Ratio
9.48
Current Ratio
9.48
Debt/Eq
0.00
LT Debt/Eq
0.00
Option/Short
No / Yes
EPS (ttm)
-2.86
EPS next Y
-0.98
EPS next Q
-0.56
EPS this Y
2.69%
EPS next Y
61.26%
EPS next 5Y
-
EPS past 3/5Y
-8.04% -23.10%
Sales past 3/5Y
- -
EPS Y/Y TTM
1.11%
Sales Y/Y TTM
-
EPS Q/Q
-50.51%
Sales Q/Q
-
Earnings
Aug 17
EPS/Sales Surpr.
-4.04% -
Insider Own
23.06%
Insider Trans
9.53%
Inst Own
58.39%
Inst Trans
-2.23%
ROA
-50.56%
ROE
-67.86%
ROIC
-97.02%
Gross Margin
-
Oper. Margin
-
Profit Margin
-
SMA20
0.35%
SMA50
-7.20%
SMA200
29.16%
Trades
Shs Outstand
22.48M
Shs Float
17.50M
Short Float
4.51%
Short Ratio
4.43
Short Interest
0.79M
52W High
3.16 -21.92%
52W Low
0.96 156.97%
Volatility
4.68% 5.91%
ATR (14)
0.13
RSI (14)
46.51
Beta
0.47
Rel Volume
0.26
Avg Volume
177.93K
Volume
47,016
Perf Week
4.66%
Perf Month
-4.63%
Perf Quarter
-3.89%
Perf Half Y
57.32%
Perf YTD
105.83%
Perf Year
78.99%
Perf 3Y
-
Perf 5Y
-
Perf 10Y
-
Recom
3.00
Target Price
4.00
Prev Close
2.48
Price
2.47
Change %
-0.40%
Consensus
Hold
Avg. Price Target
$4.00
Implied Upside
+61.9%
Analysts4incl. previous ratings
Rating Distribution2 Buy · 2 Hold · 0 Sell
DateActionAnalystRating ChangePrice Target ChangeImplied Upside
Jun 02, 2025Initiated
HH.C. Wainwright
Buy$5+102.4%
May 28, 2025Downgrade
LLeerink Partners
Outperform → Market Perform$3+21.5%
Dec 13, 2024Downgrade
GGuggenheim
Buy → Neutral
Apr 22, 2024Initiated
PPiper Sandler
Overweight$20+709.7%
Apr 22, 2024Initiated
LLeerink Partners
Outperform$25+912.1%
Apr 22, 2024Initiated
GGuggenheim
Buy$24+871.7%
Show Previous News
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
TANG KEVIN10% OwnerOct 27 '26Buy2.4010,70725,6973,022,456Oct 29 06:20 PM
TANG KEVIN10% OwnerOct 26 '26Buy2.389,60622,8623,011,749Oct 26 04:51 PM
TANG KEVIN10% OwnerOct 23 '26Buy2.386,23414,8373,002,143Oct 26 04:51 PM
TANG KEVIN10% OwnerOct 22 '26Buy2.405,80013,9202,995,909Oct 26 04:51 PM
TANG KEVIN10% OwnerOct 16 '26Buy2.34118,185276,5532,958,820Oct 20 05:49 PM
TANG KEVIN10% OwnerOct 19 '26Buy2.3331,06972,5192,989,889Oct 20 05:49 PM
TANG KEVIN10% OwnerOct 20 '26Buy2.372205212,990,109Oct 20 05:49 PM
TANG KEVIN10% OwnerAug 26 '26Sale2.9718,30054,3512,840,635Aug 28 04:16 PM
TANG KEVIN10% OwnerJul 21 '26Buy2.442,9757,2592,858,935Jul 21 07:38 PM
TANG KEVIN10% OwnerJul 20 '26Buy2.441,6233,9602,855,960Jul 21 07:38 PM
TANG KEVIN10% OwnerJul 17 '26Buy2.442656472,854,337Jul 21 07:38 PM
TANG KEVIN10% OwnerJul 14 '26Buy2.4343,878106,6242,833,981Jul 16 08:10 PM
TANG KEVIN10% OwnerJul 16 '26Buy2.4418,49145,1182,854,072Jul 16 08:10 PM
TANG KEVIN10% OwnerJul 15 '26Buy2.441,6003,9042,835,581Jul 16 08:10 PM
TANG KEVIN10% OwnerJul 13 '26Buy2.4248,211116,6712,790,103Jul 13 07:06 PM
TANG KEVIN10% OwnerJul 10 '26Buy2.4343,367105,3822,741,892Jul 13 07:06 PM
TANG KEVIN10% OwnerJul 09 '26Buy2.487172,698,525Jul 13 07:06 PM
TANG KEVIN10% OwnerJul 06 '26Buy2.4927,06267,3842,668,370Jul 08 08:06 PM
TANG KEVIN10% OwnerJul 07 '26Buy2.4815,81039,2092,684,180Jul 08 08:06 PM
TANG KEVIN10% OwnerJul 08 '26Buy2.4614,33835,2712,698,518Jul 08 08:06 PM
CRANDELL KEITH10% OwnerJul 01 '26Option Exercise1.0316,00016,48016,000Jul 06 05:44 PM
CRANDELL KEITH10% OwnerJul 01 '26Sale2.4916,00039,8400Jul 06 05:44 PM
ARCH Venture Fund IX, L.P.10% OwnerJul 01 '26Option Exercise1.0316,00016,48016,000Jul 06 05:43 PM
ARCH Venture Fund IX, L.P.10% OwnerJul 01 '26Sale2.4916,00039,8400Jul 06 05:43 PM
TANG KEVIN10% OwnerJul 01 '26Buy2.4971,612178,3142,631,487Jul 02 07:45 PM
TANG KEVIN10% OwnerJun 30 '26Buy2.5426,03066,1122,559,875Jul 02 07:45 PM
TANG KEVIN10% OwnerJul 02 '26Buy2.499,82124,4542,641,308Jul 02 07:45 PM
Boundless Bio, Inc. is a clinical-stage oncology company, which is dedicated to unlocking a new paradigm in cancer therapeutics that addresses the significant unmet need in patients with oncogene amplified tumors by targeting extrachromosomal DNA. The company was founded by Vineet Bafna, Paul Mischel, Benjamin F. Cravatt, and Jonathan E. Lim on April 10, 2018 and is headquartered in La Jolla, CA.
PresidentMs. Jessica Oien J.D.
Senior VP of FinanceMr. David Hinkle
Chief Human Resources OfficerMs. Meredith Wesley
open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR
Affiliate • Advertise • APIs • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information
Stock quotes delayed by 1 minute. Futures and options delayed by 15 minutes.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)